Gentaur Epcoritamab – Anti-CD3E / CD20 (MS4A1) Bispecific

https://www.norakbio.com/web/image/product.template/46651/image_1920?unique=1dbb3eb
(0 review)
Bridges T-cells to B-cells by binding CD3E and CD20, driving targeted B-cell depletion. Ideal for lymphoma and immunotherapy models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € VAT Excluded

1,234,567.00 VAT Excluded

Not Available For Sale

    This combination does not exist.

    Terms and Conditions
    30-day money-back guarantee
    Shipping: 2-3 Business Days


    Website URL: /shop/gma-cd3e-gentaur-epcoritamab-anti-cd3e-cd20-ms4a1-bispecific-46651
    Internal Reference: GMA-CD3E